Document text
Principal Investigator: Nitin S Baliga
Organization: INSTITUTE FOR SYSTEMS BIOLOGY
Fiscal Year: 2020
Award: $441,482
Funding agency: National Institute of Allergy and Infectious Diseases
Project Summary
The NIAID national protocol intends to enroll at least 1000 COVID19 patients in a study designed to track infected
patients through tracking, over time, their immune responses, viral load, and a variety of multi-omic analytes that
can provide deep insights into how infection by SARS-CoV-2 is revealed in host defense responses and disease-
perturbed networks. At the heart of this study is the establishment of high quality biorepositories that can be
used to quantitatively assess viral load, quantitatively interrogate viable PBMCs, and permit direct comparisons
between different patients and different time points of disease progression. The nature of the infection, with
highly differential patient outcomes, will eventually require significant computational efforts that can account for
confounding factors such as co-morbidities, the influence of various therapies that are being broadly tested in
these patients, etc. It will also almost certainly require all 1000 projected patients, if not more, to resolve some
of the most outstanding and urgent clinical questions. However, all of these results rely on establishing high
quality biobanks, resource sharing, and data sharing. This is an area in which the ISB has deep expertise and
is excited to contribute. The ISB and SMC launched a joint study designed to enroll 200 COVID19 patients
around 3/20/2020. That study has overlap with the NIAID protocol and shares a common set of over-arching
goals. Here we propose to increase that overlap and to make that accruing biobank of COVID19 patient
specimens and associated characterization data a national resource through inclusion in the NIAID protocol.
Terms: <2019 novel coronavirus><2019-nCoV><Area><Assay><Bar Codes><Bioassay><Biologic Assays><Biological Assay><Blood><Blood Plasma><Blood Reticuloendothelial System><Body Tissues><COVID><COVID-19><COVID19><Clinical><CoV disease><Collection><Computer Analysis><Consent><Contracting Opportunities><Contracts><Core Facility><Data><Data Bases><Databases><Disease><Disease Progression><Disorder><Enrollment><Funding><Goals><Heart><Host Defense><IRB><IRBs><Immune response><Immunologic Subtyping><Immunological response><Immunophenotyping><Infection><Institutes><Institutional Review Boards><Intake><Investigation><Joints><Link><Medical><Medical center><NIAID><Nasal><Nasal Passages Nose><National Institute of Allergy and Infectious Disease><Nature><Nose><Outcome><PBMC><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Peripheral Blood Mononuclear Cell><Plasma><Plasma Serum><Proteomics><Protocol><Protocols documentation><Research Design><Research Resources><Research Specimen><Resource Sharing><Resources><Respiratory System, Nose, Nasal Passages><Reticuloendothelial System, Serum, Plasma><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Sampling><Severe acute respiratory syndrome coronavirus 2><Ships><Site><Specific qualifier value><Specified><Specimen><Study Type><Swab><System><Systems Biology><Testing><Time><Tissues><Viral Burden><Viral Load><Viral Load result><Work><Wuhan coronavirus><barcode><biobank><biorepository><clinical relevance><clinically relevant><co-morbid><co-morbidity><cohort><comorbidity><computational analyses><computational analysis><computer analyses><corona virus disease><corona virus disease 2019><coronavirus disease><coronavirus disease 2019><data base><data sharing><defense response><design><designing><drug detection><drug testing><enroll><host response><immunophenotype><immunoresponse><insight><metabolism measurement><metabolomics><metabonomics><multiomics><multiple omics><physiological defense response><sample collection><specimen collection><study design>